New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
10:41 EDTRMBS, EXH, RNG, TA, IMUC, MWW, DYN, GCIHigh option volume stocks
High option volume stocks: MWW RNG VGK GCI IMUC EXH DYN TA GREK RMBS
News For MWW;RNG;GCI;IMUC;EXH;DYN;TA;RMBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
09:07 EDTDYNWolfe Research to hold a conference
Subscribe for More Information
March 29, 2015
13:46 EDTDYNDuke Energy gets approval to sell certain assets to Dynegy for $2.8B in cash
Subscribe for More Information
13:00 EDTDYNDynegy receives final approval from FERC to acquire certain assets
Subscribe for More Information
March 25, 2015
12:18 EDTDYNFranklin Resources lowers stake in Dynegy to 12.7% from 13.7%
10:03 EDTEXHHigh option volume stocks
High option volume stocks: NVO SXC SONC EXH KRFT WLB ETR LXK APOL EWH
March 23, 2015
16:35 EDTRMBSRambus licenses patents and technology solutions to IBM, terms undisclosed
Rambus (RMBS) announced it has signed both patent and technology license agreements with IBM (IBM). The patent license agreement authorizes IBM to integrate Rambus memory controller and serial link interface technologies. The technology license agreement will have Rambus develop and deliver high-performance memory interface design IP to enhance IBM systems and semiconductor offerings. Specific terms of the agreements are confidential.
March 19, 2015
09:20 EDTIMUCOn The Fly: Pre-market Movers
Subscribe for More Information
06:12 EDTIMUCImmunoCellular signs manufacturing agreement with Pharmacell B.V.
ImmunoCellular established an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma. This agreement with PharmaCell, a European contract manufacturing organization, focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015.
March 18, 2015
17:20 EDTDYNIntegrated Core Strategies reports 5.1% passive stake in Dynegy
Subscribe for More Information
07:02 EDTEXHExterran nominates five new directors to board
Exterran Holdings (EXH) announced that its Board of Directors has nominated the following individuals for election to the Exterran Holdings Board at the Company’s 2015 Annual Meeting of Stockholders on April 28: Anne-Marie N. Ainsworth – former President and CEO of the general partner of Oiltanking Partners, L.P. (OILT); Frances Powell Hawes – independent financial consultant and former CFO of NCI Building Systems (NCS); James H. Lytal – independent energy consultant and former President of Gulfterra Energy Partners LP; Richard R. Stewart- former President and CEO of GE Aero Energy (GE); and Ieda Gomes Yell – Managing Director of Energix Strategy Ltd. and former President of BP Brazil (BP). “In November 2014, we announced a plan to separate Exterran’s international contract operations, international aftermarket services and global fabrication businesses into an independent, publicly traded company in the second half of 2015,” said Mark Sotir, Executive Chairman of the Board. “Our Board has nominated these additional well qualified director candidates in anticipation of certain of Exterran’s directors resigning from the Board at the time of the separation in order to join the board of directors of the new publicly traded company. We have not yet reached a final determination regarding which directors will remain on Exterran’s Board and which directors will join the board of directors of SpinCo at the time of the separation.”
March 17, 2015
07:20 EDTRNGBofA/Merrill to hold a conference
Smid Cap Conference 2015 is being held in Boston on March 17-18.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use